生物
表达式(计算机科学)
ETS1型
小学(天文学)
差速器(机械装置)
内科学
遗传学
基因表达
医学
基因
计算机科学
天文
物理
工程类
航空航天工程
程序设计语言
作者
Peng Jiang,Chan Wang,Mingming Zhang,Ye Tian,Weifeng Zhao,Junyi Xin,Yexi Huang,Zhibin Zhao,Wenjuan Sun,Jie Long,Ruqi Tang,Fang Qiu,Xingjuan Shi,Yi Zhao,Li Zhu,Na Dai,Lei Liu,Xudong Wu,Jinshan Nie,Bo Jiang
标识
DOI:10.1016/j.jgg.2023.06.004
摘要
Osteoarthritis (OA) is one of the most common degenerative joint diseases worldwide, causing pain, disability, and decreased quality of life. The balance between regeneration and inflammation-induced degradation results in multiple etiologies and complex pathogenesis of OA. Currently, there is a lack of effective therapeutic strategies for OA treatment. With the development of CRISPR-based genome, epigenome, and RNA editing tools, OA treatment has been improved by targeting genetic risk factors, activating chondrogenic elements, and modulating inflammatory regulators. Supported by cell therapy and in vivo delivery vectors, genome, epigenome, and RNA editing tools may provide a promising approach for personalized OA therapy. This review summarizes CRISPR-based genome, epigenome, and RNA editing tools that can be applied to the treatment of OA and provides new insights into the development of CRISPR-based therapeutics for OA treatment. Moreover, in-depth evaluations of the efficacy and safety of these tools in human OA treatment are needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI